ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
Dr. Chris Otiko will be traveling to Dubai this month to finalize a 10-year, $12…
Month: June 2021
Gilde Healthcare Appoints Joep Muijrers to Lead Investments in Public Markets
Seasoned investment expert in the life science sector with impressive track-record UTRECHT, The Netherlands, June…
Valneva Announces the Availability of Documentation for its Combined General Meeting to be held as a closed meeting
Saint-Herblain (France), June 2, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine…
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. held its Annual Shareholders’ General…
Tiziana Life Sciences plc (“Tiziana” or the “Company”) Posting of Notice of Annual General Meeting
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN…
DBV Technologies to Present at Upcoming Investor Conferences
Montrouge, France, June 2, 2021 DBV Technologies to Present at Upcoming Investor Conferences DBV Technologies…
Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
Phase III JUNIPERA study met its primary endpoint, with Cosentyx® (secukinumab) showing significantly longer time…
ObsEva Announces Oral Presentation at the RCOG Virtual World Congress 2021
– Data from PROLONG Phase 2a proof-of-concept study of ebopiprant (OBE022) for spontaneous preterm labor…
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
SAN DIEGO and TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
Approval for moderate to severe pediatric patients six years and older is based on pivotal…
Cambium Networks Corporation Announces Launch of Secondary Offering
ROLLING MEADOWS, Ill., June 01, 2021 (GLOBE NEWSWIRE) — Cambium Networks Corporation (Nasdaq: CMBM) (“Cambium”),…
Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET NEW YORK, NY,…
Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, June 01, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Ceapro Announces Results of 2021 Shareholders’ Meeting
EDMONTON, Alberta, June 01, 2021 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”…
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, June 01, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Agenus to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference
LEXINGTON, Mass., June 01, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with…
Kiniksa Pharmaceuticals to Present at Goldman Sachs 42nd Annual Global Healthcare Conference
HAMILTON, Bermuda, June 01, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today…
Day One Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq:…
Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its Board of Directors
SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical…
Tauriga Sciences Inc. Introduces Innovative New Product Offering, Exclusively Available on Company’s E-Commerce Website – Super Deluxe Rainbow Pack @ $136.99 Each
June 1st PR Image Super Deluxe Rainbow Pack Unit NEW YORK, NY, June 01, 2021…